Scholars Central

EditorialPublished 2016

Ovarian Cancer Therapeutic Opportunities

Authors: De-Kuan Chang

Reproductive Immunology: Open Access

Volume 1 · Issue 2 · Pages 9

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Among women in the United States, ovarian cancer is the fifth leading cause of cancer deaths, accounting for approximately 5% of all cancer deaths, with an estimated 22,280 new cases this year [1]. There are 239,000 new diagnoses and 152,000 deaths from the disease in 2012 worldwide. The four most common subtypes of ovarian cancer are serous, endometrioid, clear cell, and mucinous carcinoma based on distinct clinical and biological behaviors. Over 60% of ovarian cancer cases are diagnosed at a late stage of distant metastases or invasion due to lack of effective screening for detection. Currently, the standard treatment approach for patient with ovarian cancer is surgical intervention followed by platinum-based drugs plus taxane chemotherapy [2,3]. The 5-year survival rate for ovarian cancer patients with stage III or IV disease is under 20%. No effective therapy is available for relapsed or metastatic disease that has failed first-line chemotherapy [4]. However, this landscape may change because of the remarkable progress in precision medicine and cancer immunotherapy.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Reproductive Immunology: Open Access.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalReproductive Immunology: Open Access
  • SubjectImmunology & Microbiology
  • SubjectReproductive Medicine & Gynaecology
  • BylineArticles whose byline prints “De-Kuan Chang”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels